T cell activation by recombinant FcεRI γ-chain immune receptors: an extracellular spacer domain impairs antigen-dependent T cell activation but not antigen recognition
- 1 June 2000
- journal article
- Published by Springer Science and Business Media LLC in Gene Therapy
- Vol. 7 (12), 1067-1075
- https://doi.org/10.1038/sj.gt.3301195
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 12 references indexed in Scilit:
- Impact of chimeric immune receptor extracellular protein domains on T cell functionGene Therapy, 1999
- A chimeric receptor that selectively targets membrane-bound carcinoembryonic antigen (mCEA) in the presence of soluble CEAGene Therapy, 1999
- Generation of the Single Chain Antibody Fragment Conserves the Idiotypic Profile of the Anti‐CD30 Monoclonal Antibody HRS3Scandinavian Journal of Immunology, 1998
- Isolation of single chain antibody fragments with specificity for cell surface antigens by phage display utilizing internal image anti-idiotypic antibodiesJournal of Immunological Methods, 1998
- A retroviral vector system ‘STITCH’ in combination with an optimized single chain antibody chimeric receptor gene structure allows efficient gene transduction and expression in human T lymphocytesGene Therapy, 1998
- Can combined T-cell- and antibody-based immunotherapy outsmart tumor cells?Immunology Today, 1998
- Adoptive transfer of in vitro-targeted, activated T lymphocytes results in total tumor regression.The Journal of Immunology, 1997
- The role of lymphocyte subsets and adhesion molecules in T cell‐dependent cytotoxicity mediated by CD3 and CD28 bispecific monoclonal antibodiesEuropean Journal of Immunology, 1995
- CD30‐specific AB1‐AB2‐AB3 internal image antibody network: Potential use as anti‐idiotype vaccine against Hodgkin's lymphomaInternational Journal of Cancer, 1993
- Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors.Proceedings of the National Academy of Sciences of the United States of America, 1993